Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Dow
Johnson and Johnson
McKesson
AstraZeneca

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,166,181

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,166,181
Title:Slow release pharmaceutical composition made of microgranules
Abstract: Pharmaceutical composition made of microparticles for the slow release of an active substance at least during a period covering the 6th month after injection of said composition, said composition comprising a group of microparticles made of a copolymer of the PLGA type which incorporate an active substance in the form of a water insoluble peptide salt; said copolymer furthermore comprising at least 75% of lactic acid and an inherent viscosity between 0.1 and 0.9 dl/g, as measured in chloroform at 25.degree. C. and at a polymer concentration of 0.5 g/dL; said microparticles furthermore having a size distribution defined as follows: --D (v,0.1) is between 10 and 30 micrometers, --D (v,0.5) is between 30 and 70 micrometers, --D (v,0.9) is between 50 and 1 10 micrometers.
Inventor(s): Ducrey; Bertrand (Martigny, CH), Garrouste; Patrick (Saxon, CH), Curdy; Catherine (Riehen, CH), Bardet; Marie-Anne (Maracon, CH), Porchet; Herve (Cugy, CH), Lundstrom; Eija (Lutry, CH), Heimgartner; Frederic (Marin-Epagnier, CH)
Assignee: Debiopharm Research & Manufacturing SA (CH)
Application Number:12/601,649
Patent Claim Types:
see list of patent claims
Composition; Formulation;

Drugs Protected by US Patent 10,166,181

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Arbor Pharms Llc TRIPTODUR KIT triptorelin pamoate FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 208956-001 Jun 29, 2017 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Allergan Sales Llc TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 022437-001 Mar 10, 2010 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,166,181

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
07109767Jun 6, 2007
PCT/IB2007/054372Oct 27, 2007
PCT Information
PCT FiledJune 06, 2008PCT Application Number:PCT/IB2008/052241
PCT Publication Date:December 11, 2008PCT Publication Number: WO2008/149320

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Express Scripts
Colorcon
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.